The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion
Open accessAbstract
p19ARF has been implicated as a key regulator of p53 stability and activation. While numerous stresses activate the p53 growth arrest pathway, those requiring p19ARF remain to be elucidated. We used p19ARF knockout mouse embryo fibroblasts to show that DNA damage and microtubule disruption require p19ARF to induce p53 responses, whereas ribonucleotide depletion and inhibition of RNA synthesis by low doses of actinomycin D do not. The data provide evidence that the arrest pathway activated by ribonucleotide depletion involves some different signal transducers than those activated by DNA damage or microtubule disruption. We also present biochemical analyses that provide insights into the mechanism by which p53 and p19ARF cooperate in normal cells to induce cell cycle arrest.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p19 Arf is not required for p53 induction by 𝛄 irradiation in vivo (25), although these observations appear to be at odds with its requirement in sustained cell cycle arrest after DNA damage in vitro (26).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [26]
In the citing paper
“p19 Arf and, to a lesser extent, p16 Ink4a have been shown to play a role in the activation of cellular senescence and immortalization on passaging of primary mouse cells in culture (26, 43, 44).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [26]
Citations
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,021
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Research works printed but not linked: 11
- 10.1128/mcb.4.9.1689-1694.1984 · DOI
- 10.1128/mcb.14.9.6264-6277.1994 · DOI
- M B Kastan, O Onyekwere, D Sidransky, B Vogelstein, R W Craig Cancer Res 51, 6304–6311 (1991).
- T Kamijo, E van de Kamp, M J Chong, F Zindy, J A Diehl, C J Sherr, P J McKinnon Cancer Res 59, 2464–2469 (1999).
- J D Moyer, P A Smith, E J Levy, R E Handschumacher Cancer Res 42, 4525–4531 (1982).
- D Chang, F Chen, F Zhang, B C McKay, M Ljungman Cell Growth Differ 10, 155–162 (1999).
- A Di Leonardo, S H Khan, S P Linke, V Greco, G Seidita, G M Wahl Cancer Res 57, 1013–1019 (1997).
- S H Khan, G M Wahl Cancer Res 58, 396–401 (1998).
- W S el-Deiry, J W Harper, P M O'Connor, V E Velculescu, C E Canman, J Jackman, J A Pietenpol, M Burrell, D E Hill, Y Wang, et al. Cancer Res 54, 1169–1174 (1994).
- C H Westphal, C Schmaltz, S Rowan, A Elson, D E Fisher, P Leder Cancer Res 57, 1664–1667 (1997).
- C H Westphal, K P Hoyes, C E Canman, X Huang, M B Kastan, J H Hendry, P Leder Cancer Res 58, 5637–5639 (1998).
Cited by
Sorted by citations
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Lowe, S. W., Cepero, E., & Evan, G. I. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,374
The Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,193
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046
The INK4a/ARF network in tumour suppression
Sherr, C. J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096061 · Cited by 1,003
Regulation of HDM2 activity by the ribosomal protein L11
Lohrum, M. A. E., Ludwig, R. L., Kubbutat, M. H. G., Hanlon, M., & Vousden, K. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00134-x · Cited by 626
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2716 · Cited by 625
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600
Divorcing ARF and p53: an unsettled case
Sherr, C. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1954 · Cited by 595
Mammalian G1- and S-phase checkpoints in response to DNA damage
Bártek, J., & Lukas, J. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00280-5 · Cited by 573
Different telomere damage signaling pathways in human and mouse cells
Smogorzewska, A., & de Lange, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf433 · Cited by 482
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
Ramirez, R. D., Morales, C. P., Herbert, B.-S., Rohde, J. M., Passons, C., Shay, J. W., & Wright, W. E. (2001) · Genes & Development · doi:10.1101/gad.859201 · Cited by 444
Saiko, P., Szakmary, A., Jaeger, W., & Szekeres, T. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.08.004 · Cited by 448
Mammalian Base Excision Repair: the Forgotten Archangel
Dianov, G. L., & Hübscher, U. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt076 · Cited by 363
The evolution of diverse biological responses to DNA damage: insights from yeast and p53
Wahl, G. M., & Carr, A. M. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-e277 · Cited by 376
Self-citationThe p53 response to DNA damage
Meek, D. W. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.027 · Cited by 329
Cell fusion induced by ERVWE1 or measles virus causes cellular senescence
Chuprin, A., Gal, H., Biron-Shental, T., Biran, A., Amiel, A., Rozenblatt, S., & Krizhanovsky, V. (2013) · Genes & Development · doi:10.1101/gad.227512.113 · Cited by 262
G1 tetraploidy checkpoint and the suppression of tumorigenesis
Margolis, R. L., Lohez, O. D., & Andreassen, P. R. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10411 · Cited by 238
Ongusaha, P. P., Kim, J., Fang, L., Wong, T. W., Yancopoulos, G. D., Aaronson, S. A., & Lee, S. W. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg129 · Cited by 198
A transactivation-deficient mouse model provides insights into Trp53 regulation and function
Jimenez, G. S., Nistér, M., Stommel, J. M., Beeche, M., Barcarse, E. A., Zhang, X.-Q., O’Gorman, S., & Wahl, G. M. (2000) · Nature Genetics · doi:10.1038/79152 · Cited by 197
Self-citationNot breathing is not an option: How to deal with oxidative DNA damage
Markkanen, E. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.09.007 · Cited by 205
The ARF tumor suppressor: Structure, functions and status in cancer
Ozenne, P., Eymin, B., Brambilla, E. M., & Gazzéri, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25511 · Cited by 189
Gizatullin, F., Yao, Y., Kung, V., Harding, M. W., Loda, M. F., & Shapiro, G. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3353 · Cited by 183
Genotoxic and non-genotoxic pathways of p53 induction
Pluquet, O., & Hainaut, P. L. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00698-x · Cited by 177
Phillips, A. C., & Vousden, K. H. (2001) · APOPTOSIS · doi:10.1023/a:1011332625740 · Cited by 144
Velimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2795 · Cited by 131
Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model
Kannan, K., Sharpless, N. E., Xu, J., O’Hagan, R. C., Bosenberg, M., & Chin, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336397100 · Cited by 116
Mutations in the INK4a/ARF Melanoma Susceptibility Locus Functionally Impair p14ARF
Rizos, H., Darmanian, A., Holland, E. A., Mann, G. J., & Kefford, R. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105299200 · Cited by 113
ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Korgaonkar, C. K., Zhao, L., Modestou, M., & Quelle, D. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.196-206.2002 · Cited by 111
Knudson, A. G. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.1 · Cited by 110
Lee, C., Smith, B. A., Bandyopadhyay, K., & Gjerset, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1759 · Cited by 106
Inoue, K., Wen, R., Rehg, J. E., Adachi, M., Cleveland, J. L., Roussel, M. F., & Sherr, C. J. (2000) · Genes & Development · doi:10.1101/gad.14.14.1797 · Cited by 107
Eymin, B., Claverie, P., Salon, C., Leduc, C., Col, E., Brambilla, E. M., Khochbin, S., & Gazzéri, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02240-05 · Cited by 111
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 92
Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 90
Self-citationGrønbæk, K., Worm, J., Ralfkiaer, E. M., Ahrenkiel, V., Hokland, P., & Guldberg, P. (2002) · Blood · doi:10.1182/blood-2002-02-0382 · Cited by 85
Overexpression of c-Myc Alters G 1 /S Arrest following Ionizing Radiation
Sheen, J.-H., & Dickson, R. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1819-1833.2002 · Cited by 76
DNA damage, p14ARF, Nucleophosmin (NPM/B23), and cancer
Gjerset, R. A. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9040-y · Cited by 71
ARF Differentially Modulates Apoptosis Induced by E2F1 and Myc
Russell, J. L., Powers, J. T., Rounbehler, R. J., Rogers, P. M., Conti, C. J., & Johnson, D. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1360-1368.2002 · Cited by 72
Association of p14ARF with the p120E4FTranscriptional Repressor Enhances Cell Cycle Inhibition
Rizos, H., Diefenbach, E., Badhwar, P., Woodruff, S., Becker, T. M., Rooney, R. J., & Kefford, R. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210978200 · Cited by 64
Oncogenes and senescence: breaking down in the fast lanePreprint
Hemann, M. T., & Narita, M. (2007) · Genes & Development · doi:10.1101/gad.1514207 · Cited by 66
Quignon, F., Rozier, L., Lachagès, A.-M., Bieth, A., Simili, M., & Debatisse, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209787 · Cited by 62
Ho, C.-C., Huang, A., Yu, C.-S., Lien, J., Wu, S., Huang, Y., Huang, H.-Y., Kuo, J.-H., Liao, W.-Y., Yang, J., et al. (2013) · Environmental Toxicology · doi:10.1002/tox.21857 · Cited by 57
Differential Effects on ARF Stability by Normal versus Oncogenic Levels of c-Myc Expression
Chen, D., Kon, N., Zhong, J., Zhang, P., Yu, L., & Gu, W. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.006 · Cited by 55
A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2
Wang, J., He, X., Luo, Y., & Yarbrough, W. G. (2005) · Biochemical Journal · doi:10.1042/bj20050960 · Cited by 53
Khoo, C. M., Carrasco, D. R., Bosenberg, M. W., Paik, J.-H., & DePinho, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700093104 · Cited by 52
p53-Induced Apoptosis Occurs in the Absence of p14ARF in Malignant Pleural Mesothelioma
Hopkins-Donaldson, S., Belyanskaya, A. L., Simões‐Wüst, A. P., Sigrist, B., Kurtz, S., Zangemeister‐Wittke, U., & Stahel, R. A. (2006) · Neoplasia · doi:10.1593/neo.06148 · Cited by 47
Effect of Surface Coating of Gold Nanoparticles on Cytotoxicity and Cell Cycle Progression
Li, Q., Huang, C., Liu, L., Hu, R. H., & Qu, J. (2018) · Nanomaterials · doi:10.3390/nano8121063 · Cited by 47
Carlos, A. R., Escandell, J. M., Kotsantis, P., Suwaki, N., Bouwman, P., Badie, S., Folio, C., Benitez, J. J., Goméz-López, G., Pisano, D. G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3697 · Cited by 47
Modestou, M., Puig-Antich, V., Korgaonkar, C. K., Eapen, A. K., & Quelle, D. E. (2001) · PubMed · Cited by 44
p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts
Khan, S. H., Guevara, C. I., Fujii, G., & Parry, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207824 · Cited by 41
Self-citationARF mutation accelerates pituitary tumor development in Rb +/− mice
Tsai, K. Y., MacPherson, D. P., Rubinson, D. A., Nikitin, A. Y., Bronson, R. T., Mercer, K. L., Crowley, D. G., & Jacks, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262499599 · Cited by 43
A Defect in the p53 Response Pathway Induced by de Novo Purine Synthesis Inhibition
Bronder, J. L., & Moran, R. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304844200 · Cited by 42
A Novel Nuclear Interactor of ARF and MDM2 (NIAM) That Maintains Chromosomal Stability
Tompkins, V. S., Hagen, J., Frazier, A. A., Lushnikova, T., Fitzgerald, M. P., Tommaso, A. D., Ladevèze, V., Domann, F. E., Eischen, C. M., & Quelle, D. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609612200 · Cited by 40
ATM activity contributes to the tumor-suppressing functions of p14ARF
Li, Y., Wu, D., Chen, B., Ingram, A. J., He, L., Liu, L., Zhu, D., Kapoor, A., & Tang, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207957 · Cited by 37
Wu, K. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i1.26 · Cited by 37
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
Chen, S., Bigner, S. H., & Modrich, P. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241508098 · Cited by 36
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Tan, K. H., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_9 · Cited by 38
Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2
Palmero, I., Murga, M., Zubiaga, A. M., & Serrano, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205371 · Cited by 35
Al-Saran, N., Subash‐Babu, P., Al-Nouri, D. M., Alfawaz, H., & Alshatwi, A. A. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.08.002 · Cited by 33
Shamanin, V. A., & Androphy, E. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2144-2152.2004 · Cited by 32
Deregulation of the Cell Cycle by the Epstein–Barr Virus
O’Nions, J., & Allday, M. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92006-4 · Cited by 28
Integration of the PRB and P53 Cell Cycle Control Pathways
Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 27
David-Pfeuty, T., & Nouvian-Dooghe, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205871 · Cited by 26
Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability
Nitta, M., Tsuiki, H., Arima, Y., Harada, K., Nishizaki, T., Sasaki, K., Mimori, T., Ushio, Y., & Saya, H. (2002) · Genes to Cells · doi:10.1046/j.1356-9597.2001.00509.x · Cited by 25
Mdm2 Regulates p53 Independently of p19ARF in Homeostatic Tissues
O’Leary, K. A., Mendrysa, S. M., Vaccaro, A. M., & Perry, M. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.186-191.2004 · Cited by 25
Regulation of p53 after Different Forms of Stress and at Different Cell Cycle StagesPreprint
Gottifredi, V., Shieh, S.-Y., & Prives, C. L. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.483 · Cited by 25
Tommaso, A. D., Hagen, J., Tompkins, V. S., Muniz, V. P., Dudakovic, A., Kitzis, A., Ladevèze, V., & Quelle, D. E. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.01.010 · Cited by 23
NMI mediates transcription-independent ARF regulation in response to cellular stresses
Li, Z., Hou, J., Sun, L., Wen, T., Wang, L., Zhao, X., Xie, Q., & Zhang, S. Q. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-04-0304 · Cited by 25
A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression
Zhang, Z., Wang, Y., Herzog, C. R., Liu, G., Lee, H., DePinho, R. A., & You, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205725 · Cited by 24
Subash‐Babu, P., Alshammari, G. M., Savarimuthu Ignacimuthu, S. J., & Alshatwi, A. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.091 · Cited by 22
Vestey, S. B., Sen, C., Calder, C. J., Perks, C. M., Pignatelli, M. N., & Winters, Z. (2004) · Breast Cancer Research · doi:10.1186/bcr912 · Cited by 20
Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death
Lee, C. K., Yang, Y., Chen, C., & Liu, J. (2015) · Oncogene · doi:10.1038/onc.2015.275 · Cited by 21
Saadatmandi, N., Tyler, T., Huang, Y., Haghighi, A. P., Frost, G., Borgström, P., & Gjerset, R. A. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700505 · Cited by 20
Regulation of p53-dependent transcription
Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 20
p19Arf is required for the cellular response to chronic DNA damage
Bieging-Rolett, K. T., Johnson, T. M., Brady, C. A., Beaudry, V. G., Pathak, N., Han, S., & Attardi, L. D. (2016) · Oncogene · doi:10.1038/onc.2015.490 · Cited by 19
INK4a/ARF limits the expansion of cells suffering from replication stress
Monasor, A., Murga, M., Lopez-Contreras, A. J., Navas, C., Goméz-López, G., Pisano, D. G., & Fernández-Capetillo, Ó. (2013) · Cell Cycle · doi:10.4161/cc.25017 · Cited by 16
E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway
Russell, J., Weaks, R. L., Berton, T. R., & Johnson, D. G. (2005) · Oncogene · doi:10.1038/sj.onc.1209120 · Cited by 17
The INK4a/ARF Locus and Human Cancer
Enders, G. H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:197 · Cited by 10
Prindull, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.009 · Cited by 9
Reversal of TNP-470-Induced Endothelial Cell Growth Arrest by Guanine and Guanine Nucleosides
Hines, J. F., Ju, R., Dutschman, G. E., Cheng, Y., & Crews, C. M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169110 · Cited by 9
The INK4A/Arf Network — Cell Cycle Checkpoint or Emergency Brake?
del Arroyo, A. G., & Peters, G. G. (2005) · Advances in experimental medicine and biology · doi:10.1007/1-4020-3764-3_8 · Cited by 8
Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 9
Self-citationModelling the p53 gene regulatory network.
Brewer, D. S. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 7
Russo, P., Ottoboni, C., Malacarne, D., Crippa, A., Riou, J., & O’Connor, P. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.220 · Cited by 6
The DNA Damage Response Mediates Apoptosis and Tumor Suppression
Baran, K., Rodríguez, D. A., & Green, D. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_7 · Cited by 6
Ottoboni, C. (2001) · Mutagenesis · doi:10.1093/mutage/16.5.423 · Cited by 5
Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!
Vashi, R., & Patel, B. M. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03996-0 · Cited by 4
IRES-Mediated Protein Translation Overcomes Suppression by the p14ARF Tumor Suppressor Protein
Xi, S., Zhao, M., Wang, S., Ma, L., Wang, S., Cong, X., Gjerset, R. A., Fitzgerald, R. C., & Huang, Y. (2017) · Journal of Cancer · doi:10.7150/jca.17457 · Cited by 3
Treanor (2010) · International Journal of Oncology · doi:10.3892/ijo_00000650 · Cited by 3
The ARF protein in tumor suppression: lessons from mouse models and human tumors
Rodríguez, I. P. (2004) · Clinical & Translational Oncology · doi:10.1007/bf02710031 · Cited by 2
Microcephaly Gene Mcph1 Deficiency Induces p19ARF-Dependent Cell Cycle Arrest and Senescence
Jiang, Y.-N., Gao, Y., Lai, X., Li, X., Liu, G., Ding, M., Wang, Z., Guo, Z., Qin, Y., Li, X., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094597 · Cited by 2
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_5 · Cited by 2
Genomic, epigenomic and transcriptomic regulation of cellular senescence
Salekeen, R., Kieu, T. L., Robbins, P. D., Niedernhofer, L. J., & Laux, L. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00982-y · Cited by 2
The Role of p14ARF Methylation in Neuroblastoma Minimal Residual Disease
Erbayraktar, Z., Zadeoğluları, Z., Aktaş, S., Ellıdokuz, H., Kırkalı, G., & Olgun, N. (2012) · Turkish Journal of Biochemistry · doi:10.5505/tjb.2012.57966 · Cited by 1
Boșoteanu, L.-A., Gheorghe, E., Aşchie, M., Cozaru, G. C., Deacu, M., Orǎșanu, C. I., & Boșoteanu, M. (2023) · Medicine · doi:10.1097/md.0000000000036756 · Cited by 1
Klotzbücher, A., & Kubbutat, M. H. G. (2002) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-59259-153-4_10 · Cited by 1
Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7
Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
The regulation of RNA polymerase III-mediated transcription by p53, AP-1 and JNKs
Dowding, S. N. (2013) · Enlighten: Theses (The University of Glasgow)
Effect of aberrant ribosome biogenesis on wild-type and mutant p53 in cancer cells
Ferro, M. D. (2014) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
Metadata
- Authors
- Khan, S. H., Moritsugu, J., & Wahl, G. M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Wahl, Geoffrey M.
- ORCID
- Wahl, Geoffrey M.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-03-14
- Volume
- 97
- Issue
- 7
- Pages
- 3266-3271
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC16227
- OpenAlex
- W2090930894
- Cited by
- 103
- References
- 61
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 9 · 2012: 3
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA61449, R01CA061449, 1T32CA64041, T32CA064041)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p19ARF, p53, cell cycle arrest, DNA damage response, microtubule disruption, actinomycin D, p53 stabilization, p53 activation, signal transduction, p16INK4a
- MeSH terms
- Animals, Cells, Cultured, DNA Damage, Microtubules, Polyploidy, Proteins, Ribonucleotides, Blotting, Western, Nocodazole, Tumor Suppressor Protein p53, Mice, Knockout, Tumor Suppressor Protein p14ARF, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review